G vs EPAM
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
G · Genpact$42.27 ▲ 2.85%
EPAM · EPAM Systems$159.31 ▼ 3.86%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- G -3.0%
- EPAM -12.7%
Head to head
| Metric | G | EPAM |
|---|---|---|
| Price | $42.27 | $159.31 |
| Change today | ▲ 2.85% | ▼ 3.86% |
| Market cap | $7.07B | $8.13B |
| Return, 3 months | +24.5% | +63.6% |
| Return, year to date | -8.2% | -22.2% |
| Return, 1 year | -3.4% | -9.1% |
| P/E (TTM) | 12.3 | 20.0 |
| P/B | 2.6 | 2.3 |
| P/E percentile vs own 5y | 27th | 12th |
| Dividend yield | 1.73% | – |
| Revenue growth (YoY, latest qtr) | +7.1% | +4.5% |
| Net profit growth (YoY) | +9.8% | +17.0% |
| Gross margin | 36.5% | 29.4% |
| Operating margin | 15.0% | 10.0% |
| Net margin | 11.1% | 7.2% |
| Return on equity | 22.4% | 11.2% |
| Analyst target vs. price | -1.5% | -19.3% |
| Analyst buy share | 33% | 54% |
| RSI (14) | 71 | 71 |
| 30-day volatility | 39.9% | 69.4% |
| Max drawdown, 1 year | -42.7% | -65.7% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- EPAM is the largest of the group by market value.
- G has returned the most over the past year.
- G carries the lowest trailing P/E.
- G is growing revenue fastest.
- G keeps the most profit per dollar of sales.
- G has been the calmest stock over the last 30 days.